InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Sunday, 01/14/2018 9:27:47 AM

Sunday, January 14, 2018 9:27:47 AM

Post# of 462153
https://finance.yahoo.com/news/2018-biogen-inc-apos-best-131800182.html

Interesting. MS is massive part of BIIB revenue. Does A2-73 present a threat? The dynamics of this competitive scenario alone suggest a set of conditions that cannot last long.(boom) It is a one or a zero. I have a family member w/MS. She deserves an effective and fairly priced treatment.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News